Common Contracts
9 similar Common Stock Private Purchase Agreement contracts by Nymox Pharmaceutical Corp
COMMON STOCK PRIVATE PURCHASE AGREEMENTCommon Stock Private Purchase Agreement • March 31st, 2016 • Nymox Pharmaceutical Corp • In vitro & in vivo diagnostic substances • Quebec
This COMMON STOCK PRIVATE PURCHASE AGREEMENT (this “Agreement’) is dated as of November 1, 2013 by and between Nymox Pharmaceutical Corporation, a Canadian corporation (the “Company”), and Lorros-Greyse Investments, Ltd. (the “Purchaser”).
COMMON STOCK PRIVATE PURCHASE AGREEMENTCommon Stock Private Purchase Agreement • March 15th, 2013 • Nymox Pharmaceutical Corp • In vitro & in vivo diagnostic substances • Quebec
This COMMON STOCK PRIVATE PURCHASE AGREEMENT (this “Agreement’) is dated as of November 1, 2012 by and between Nymox Pharmaceutical Corporation, a Canadian corporation (the “Company”), and Lorros-Greyse Investments, Ltd. (the “Purchaser”).
COMMON STOCK PRIVATE PURCHASE AGREEMENTCommon Stock Private Purchase Agreement • March 15th, 2012 • Nymox Pharmaceutical Corp • In vitro & in vivo diagnostic substances • Quebec
This COMMON STOCK PRIVATE PURCHASE AGREEMENT (this “Agreement’) is dated as of November 1, 2011 by and between Nymox Pharmaceutical Corporation, a Canadian corporation (the “Company”), and Lorros-Greyse Investments, Ltd. (the “Purchaser”).
COMMON STOCK PRIVATE PURCHASE AGREEMENTCommon Stock Private Purchase Agreement • June 3rd, 2011 • Nymox Pharmaceutical Corp • In vitro & in vivo diagnostic substances • Quebec
This COMMON STOCK PRIVATE PURCHASE AGREEMENT (this “Agreement’) is dated as of November 1, 2010 by and between Nymox Pharmaceutical Corporation, a Canadian corporation (the “Company”), and Lorros-Greyse Investments, Ltd. (the “Purchaser”). The parties hereto agree as follows:
COMMON STOCK PRIVATE PURCHASE AGREEMENTCommon Stock Private Purchase Agreement • March 14th, 2008 • Nymox Pharmaceutical Corp • In vitro & in vivo diagnostic substances • Quebec
This COMMON STOCK PRIVATE PURCHASE AGREEMENT (this “Agreement’) is dated as of November 16, 2007 by and between Nymox Pharmaceutical Corporation, a Canadian corporation (the “Company”), and Lorros-Greyse Investments, Ltd. (the “Purchaser”).
COMMON STOCK PRIVATE PURCHASE AGREEMENTCommon Stock Private Purchase Agreement • March 15th, 2007 • Nymox Pharmaceutical Corp • In vitro & in vivo diagnostic substances • Quebec
This COMMON STOCK PRIVATE PURCHASE AGREEMENT (this “Agreement’) is dated as of November 13, 2006 by and between Nymox Pharmaceutical Corporation, a Canadian corporation (the “Company”), and Lorros-Greyse Investments, Ltd. (the “Purchaser”).
COMMON STOCK PRIVATE PURCHASE AGREEMENTCommon Stock Private Purchase Agreement • June 30th, 2006 • Nymox Pharmaceutical Corp • In vitro & in vivo diagnostic substances • Quebec
This COMMON STOCK PRIVATE PURCHASE AGREEMENT (this “Agreement’) is dated as of October 21, 2005 by and between Nymox Pharmaceutical Corporation, a Canadian corporation (the “Company”), and Lorros-Greyse Investments, Ltd. (the “Purchaser”).
COMMON STOCK PRIVATE PURCHASE AGREEMENTCommon Stock Private Purchase Agreement • November 16th, 2004 • Nymox Pharmaceutical Corp • In vitro & in vivo diagnostic substances • Quebec
This COMMON STOCK PRIVATE PURCHASE AGREEMENT (this “Agreement’) is dated as of October 6, 2004 by and between Nymox Pharmaceutical Corporation, a Canadian corporation (the “Company”), and Lorros-Greyse Investments, Ltd. (the “Purchaser”).
COMMON STOCK PRIVATE PURCHASE AGREEMENTCommon Stock Private Purchase Agreement • November 14th, 2003 • Nymox Pharmaceutical Corp • In vitro & in vivo diagnostic substances • Quebec
This COMMON STOCK PRIVATE PURCHASE AGREEMENT (this “Agreement’) is dated as of August 25, 2003 by and between Nymox Pharmaceutical Corporation, a Canadian corporation (the “Company”), and Lorros-Greyse Investments, Ltd. (the “Purchaser”).
